Eupraxia Pharmaceuticals Inc. (EPRX) income statement
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.80−0.32 (-5.23%)
Close on Nov 20, 2026Market cap $349.71MP/E –Yield –
Eupraxia Pharmaceuticals Inc. financial ratios
See a number that looks wrong?